ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 D75.839

Billable / Specific

Thrombocytosis, unspecified

D75
Block
2
Synonyms
68
LCDs
9
Payer Policies
0
Linked CPTs

About ICD-10-CM D75.839

ICD-10-CM code D75.839 represents Thrombocytosis, unspecified. This is a billable/specific code in the Blood and Blood-forming Organs chapter (block D75). The 2026 edition of ICD-10-CM D75.839 became effective on October 1, 2025.

Inclusion Terms / Approximate Synonyms

Clinical terms and conditions classified under D75.839. Per CMS ICD-10-CM Tabular 2026.

  • Thrombocythemia NOS
  • Thrombocytosis NOS

Medicare LCD Coverage for D75.839

Local Coverage Determinations (LCDs) from CMS MACs that list D75.839 as a covered diagnosis.

68 LCDs

Showing top 10 of 68 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81451 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81450 →
CMS LCD: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Article ID: 57891, Effective: 2026-02-05 00:00:00, 91 covered, 0 non-covered
CPT 81170 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 0027U →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 81219 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 81339 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 81207 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Article ID: 59919, Effective: 2025-11-20 00:00:00, 14 covered, 0 non-covered
CPT 81206 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing D75.839.

9 policies

5 Medicare

Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
Policy ID: ART-56795
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57837
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57873
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57878
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
Policy ID: ART-57891

CPT Codes Commonly Billed with D75.839

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for D75.839

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

ICD-10 D75.839, Billing FAQ

Is ICD-10 code D75.839 billable? +

Yes, D75.839 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What other names or terms map to D75.839? +

ICD-10 D75.839 includes: Thrombocythemia NOS; Thrombocytosis NOS.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on June 2, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included